Invex Therapeutics Ltd (ASX:IXC)
Australia flag Australia · Delayed Price · Currency is AUD
0.110
0.00 (0.00%)
Mar 9, 2026, 3:03 PM AEST

Invex Therapeutics Market Cap

Invex Therapeutics has a market cap or net worth of 8.27 million as of March 9, 2026. Its market cap has increased by 37.50% in one year.

Market Cap
8.27M
Enterprise Value
3.67M
Revenue
229.08K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11

Market Cap Chart

Since July 5, 2019, Invex Therapeutics's market cap has decreased from 59.13M to 8.27M, a decrease of -86.02%. That is a compound annual growth rate of -25.50%.

History

DateMarket Cap% Change
Mar 9, 20268.27M-8.33%
Dec 30, 20259.02M81.82%
Dec 23, 20244.96M-18.52%
Dec 27, 20236.09M-85.14%
Dec 28, 202240.96M-22.70%
Dec 31, 202152.98M-1.40%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Chimeric Therapeutics 8.84M
Immuron 9.80M
Tissue Repair 9.98M
Biotron 8.11M
Bio-Gene Technology 11.29M
AdAlta 11.47M
Vectus Biosystems 6.68M
Zelira Therapeutics 5.95M
Market Cap Rankings